Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,564.11
    -1,456.87 (-2.91%)
     
  • CMC Crypto 200

    1,256.24
    -101.77 (-7.49%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

BUZZ-Shire: shares do U-turn after misses Q2 forecast

** Shire (Xetra: S7E.DE - news) , which spent the morning among the FTSE 100's top risers, left nursing 2.3% drop which puts it near bottom of index as misses market expectations for Q2 earnings

** Blames lower sales of its ADHD drug Intuniv following the introduction of generic competition

** Non-GAAP EPS of $2.63 vs $2.80 forecast by analysts

** One of most actively traded UK blue-chip stocks, with nearly all of its 90-day daily avg volume having gone through (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)